AIVF News
13 articles
הסטארט-אפ AIVF מגבש פורום להתמודדות עם טיפולי פוריות בעת מלחמה
Israeli start-up AIVF, which develops artificial intelligence-based solutions for fertility, is setting up a multi-disciplinary forum to support women undergoing IVF treatment during uncertain times. The forum will meet once a week to discuss relevant issues and will include experts in the fields of fertility, nutrition, embryology, and mental health. The initiative is aimed at creating a supportive environment and providing professional answers to those grappling with fertility and pregnancy issues.
CustomersExpand
AIVF Expands Launching the First AI-Powered IVF Solution at the Perfetto Clinic in Goiânia, Brazil
AIVF, a reproductive technology company, has launched the first AI-powered IVF operating system in Brazil at Perfetto, a multidisciplinary fertility clinic. The expansion aims to address the growing demand for assisted reproductive technologies in Brazil. AIVFs EMA™ is designed to improve clinical decision-making, streamline operations, and strengthen clinic-patient communications. The systems deep learning AI models were developed on large and diverse databases from leading institutions across the US, Europe, and Asia. The launch is part of AIVFs efforts to meet the increasing demand for advanced fertility solutions.
CustomersExpand
AIVF Awarded as 2023 Technology Pioneer by World Economic Forum
AIVF, a Tel Aviv-based developer of AI-based solutions for IVF clinics, has been selected as one of the World Economic Forums Technology Pioneers. AIVF uses artificial intelligence to optimize the IVF journey. As a Technology Pioneer, AIVF will engage with the World Economic Forum and work with global leaders to address industry and societal issues. The Technology Pioneer cohort includes startups from 31 economies, with a third led by a woman chief executive. AIVF is developing generative AI models to maximize success rates and streamline the clinical process in the IVF lab.
PartnersCustomers
Fertility Companies AIVF and Genea Biomedx Partner to Improve IVF Success Rates and Care
AIVF has formed a partnership with Genea Biomedx to enhance the efficiency and success rates of IVF clinics worldwide. The partnership integrates AIVFs AI platform with Genea Biomedxs time-lapse incubator, offering personalized and optimized IVF care. The solution reduces costs for patients and improves clinic revenues by increasing efficiency and patient access. AIVFs suite of solutions connects patients, clinics, and labs, providing transparent insights and data for IVF treatments. The partnership signifies a new generation of data-driven IVF clinics. The integrated solution has been tested and validated, showing improved success rates and birthrates.
Partners
Israeli IVF startup looks to democratize fertility coverage in the United States
AIVF, a company specializing in in-vitro fertilization (IVF), is using AI to improve success rates and make IVF more accessible. In the United States, the cost of IVF treatment is high and insurance coverage is limited, creating a gap in coverage for many women. AIVF, founded by Daniella Gilboa, aims to address this issue by expanding in the US and working with health plans to lower the cost of IVF treatment. The company recently raised $25 million in Series A funding and acquired ART Compass, a company that develops lab-management software for IVF. AIVFs AI platform helps assess embryo quality and improve success rates. In Israel, where IVF is more accessible, 5% of babies are born through IVF compared to 2% in the US.
ExpandInvestmentAcquisition
AIVF ACQUIRES ART COMPASS TO DRIVE THE DIGITAL TRANSFORMATION OF FERTILITY CARE
Reproductive technology company AIVF has announced the acquisition of ART Compass, a leading application for the management of the IVF laboratory. This acquisition expands AIVFs offering and creates traction in the US with an extensive user base. The integration of ART Compass into AIVFs platform for fertility clinics is planned for Q1 2023.
Acquisition
AiVF Raises $25 Million in Series A Round Led by Insight Partners to Help More People Become Parents
AiVF receives European CE Mark for its AI-based IVF treatments
AiVF has received the European stamp of approval for its AI-based digital embryology management platform, EMA, and is seeking approval in the U.S. The platform aims to improve the success rates of IVF treatment by combining AI, computer vision, and big data. The company has the largest embryo database in the world and offers objective and automatic tools. AiVFs solution could lower the cost of IVF treatments and improve the chances of successful pregnancies. The company has also welcomed Dan Ariely as its Chief Behavioral Officer to develop social and behavioral strategies for IVF treatment. AiVF was founded in 2018 and is backed by private equity and scientific grants.
CustomersExpand
Israeli researchers devise non-invasive genetic testing screens to ensure healthy fetuses
Israeli biotech startup AIVF has developed a noninvasive method for testing embryos in vitro to detect genetic abnormalities using artificial intelligence. The technology uses a scanning device and an algorithm to analyze a larger data sample, providing a clearer picture of whether an embryo is normal or not. The traditional method of preimplantation genetic testing (PGT) using a biopsy is often unreliable and can harm the embryo. AIVFs technology aims to address these issues and improve the accuracy of embryo testing. The company is currently conducting clinical trials in Spain and plans to expand to hospitals and clinics in the US and Europe. The technology has the potential to change the approach to in vitro fertilization (IVF) and improve outcomes.
CustomersPartners
Can AI Lead to Pregnancy?
Israeli machine learning startup AiVF is using artificial intelligence (AI) to improve the success rate of in vitro fertilization (IVF). The companys AI system could potentially triple the success rate of IVF compared to traditional methods. AiVF uses machine learning and computer vision technology to allow embryologists to discover which embryos have the most potential for success during intrauterine implantation. The company is currently working with eight facilities in clinical trials around the world, including in Israel, Europe, and the United States, and plans to launch commercially in 2021.
CustomersExpand
AIVF deploys technology and innovation to boost reproductive science
This Israeli Startup is Using Deep Learning and Computer Vision to Revolutionize IVF Treatments
Israeli startup AIVF is developing an artificial intelligence (AI) based system to optimize the embryo selection process in In-Vitro Fertilization (IVF) treatments. The AI system is designed to increase success rates, reduce costs, and increase lab capacity. AIVF has partnered with Israeli private hospital Assuta and eight other clinics worldwide, and currently holds the largest dataset of over 250,000 time-lapse videos of developing embryos. The company plans to start clinical trials in 2020 and aims to receive regulatory approval for usage of the system in clinics in 2021.
PartnersExpand
Pitango's $1 Million Startup Competition Semi-Finalists Unveiled in New York
Pitango Venture Capital unveiled the 11 semi-finalists of its $1 million startup competition at Calcalists Mind the Tech Conference. The competition focuses on the intersection of data, machines, and humans. The semi-finals were held in New York, with the finals scheduled to take place in Israel in June. The startups showcased various technologies, including pool safety cameras, computer vision solutions, artificial intelligence for IVF embryo selection, and more. The competition aims to support and promote innovative startups in the tech industry.
Investment